August 17, 2022



U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549


Attention: Ms. Dorrie Yale


Re: Acutus Medical, Inc.
Registration Statement on Form S-3
Registration No. 333-266804


Dear Ms. Yale:


In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-3 (File No. 333-266804) (the “Registration Statement”) of Acutus Medical, Inc. We respectfully request that the Registration Statement be declared effective as of 4:00 P.M. Eastern Time on August 19, 2022, or as soon as practicable thereafter, or at such other time as our legal counsel, Davis Polk & Wardwell LLP, may request by a telephone call to the staff of the U.S. Securities and Exchange Commission.


Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Davis Polk & Wardwell LLP, by calling Alan F. Denenberg at (650) 752-2004 or Jason Bassetti at (650) 752-2071.


[Signature page follows]



Very truly yours,


Acutus Medical, Inc.


By: /s/ David Roman  
  Name:  David Roman  
  Title:   Chief Executive Officer and Chief Financial Officer